UBS Group AG - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 22 filers reported holding TRINITY BIOTECH PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$104
-99.1%
142
-98.8%
0.00%
Q1 2023$11,366
+2339.1%
12,092
+2467.3%
0.00%
Q4 2022$466
-95.3%
471
-95.0%
0.00%
Q3 2022$10,000
+900.0%
9,471
+1251.1%
0.00%
Q1 2022$1,000
-88.9%
701
-89.1%
0.00%
Q4 2021$9,000
+800.0%
6,429
+962.6%
0.00%
Q3 2021$1,000
-88.9%
605
-81.0%
0.00%
Q2 2021$9,000
+350.0%
3,186
+474.1%
0.00%
Q1 2021$2,000
-60.0%
555
-56.8%
0.00%
Q4 2020$5,000
-70.6%
1,285
-91.5%
0.00%
Q1 2020$17,000
+325.0%
15,144
+265.3%
0.00%
Q4 2019$4,000
+300.0%
4,146
+916.2%
0.00%
Q2 2019$1,000
-50.0%
408
-28.0%
0.00%
Q3 2018$2,000
-66.7%
567
-50.4%
0.00%
Q1 2018$6,000
+500.0%
1,143
+321.8%
0.00%
Q4 2017$1,000
-92.3%
271
-87.3%
0.00%
Q1 2017$13,000
+160.0%
2,136
+177.8%
0.00%
Q4 2016$5,000
-28.6%
769
+26.3%
0.00%
Q2 2016$7,000
-75.0%
609
-73.7%
0.00%
Q1 2016$28,000
+600.0%
2,319
+673.0%
0.00%
Q4 2015$4,000
-78.9%
300
-82.0%
0.00%
Q3 2015$19,000
+46.2%
1,663
+137.6%
0.00%
Q2 2015$13,000
-74.5%
700
-73.7%
0.00%
Q1 2015$51,000
-19.0%
2,658
-26.2%
0.00%
Q4 2014$63,0003,6000.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2022
NameSharesValueWeighting ↓
ACK Asset Management 657,100$11,072,0004.49%
GOLDMAN CAPITAL MANAGEMENT INC 343,000$5,780,0003.30%
Lyon Street Capital, LLC 368,858$6,215,257,0003.08%
JAY JEFFREY R 163,140$2,749,0002.17%
Adirondack Research & Management Inc. 161,507$2,721,0002.03%
Park West Asset Management LLC 448,415$7,556,0000.89%
Benchmark Capital Advisors 51,600$869,0000.67%
SHEPHERD KAPLAN KROCHUK, LLC 166,034$2,797,0000.55%
HEARTLAND ADVISORS INC 1,569,699$26,449,0000.49%
WOODMONT INVESTMENT COUNSEL LLC 86,682$1,461,0000.49%
View complete list of TRINITY BIOTECH PLC shareholders